DrugPatentWatch Database Preview
Akarx Inc Company Profile
What is the competitive landscape for AKARX INC, and when can generic versions of AKARX INC drugs launch?
AKARX INC has one approved drug.
There are two US patents protecting AKARX INC drugs.
Summary for Akarx Inc
| US Patents: | 2 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Akarx Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akarx Inc | DOPTELET | avatrombopag maleate | TABLET;ORAL | 210238-001 | May 21, 2018 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Akarx Inc | DOPTELET | avatrombopag maleate | TABLET;ORAL | 210238-001 | May 21, 2018 | RX | Yes | Yes | 7,638,536 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Akarx Inc | DOPTELET | avatrombopag maleate | TABLET;ORAL | 210238-001 | May 21, 2018 | RX | Yes | Yes | 8,765,764 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Akarx Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| China | 1319967 | ➤ Sign Up |
| Japan | WO2003062233 | ➤ Sign Up |
| Denmark | 1466912 | ➤ Sign Up |
| South Korea | 20040078122 | ➤ Sign Up |
| Japan | 4120586 | ➤ Sign Up |
| European Patent Office | 1466912 | ➤ Sign Up |
| Portugal | 1466912 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
